In the BioHarmony Drug Report Database
Megestrol
Megace, Megace Es (megestrol acetate) is a small molecule pharmaceutical. Megestrol acetate was first approved as Megace on 1982-01-01. It is used to treat anorexia, breast neoplasms, cachexia, and endometrial neoplasms in the USA. Megestrol acetate’s patent is valid until 2024-04-22 (FDA).
Trade Name
|
Megace, Megace Es |
|---|---|
Common Name
|
megestrol acetate |
ChEMBL ID
|
CHEMBL1201139 |
Indication
|
anorexia, breast neoplasms, cachexia, endometrial neoplasms |
Drug Class
|
Estrogens; progestins |
Image (chem structure or protein)